Medicilon Settled in Baoshan District, Biomedical Industrial Park in Northern Shanghai Welcoming New Member
Source: Shanghaibaoshan Author: Public Time: 2022-01-17 14:49

微信图片_20220107091129.jpg

As an important pillar industry for Baoshan District to build the main position of the city's science and technology innovation center, biomedical industry is growing vigorously with the deepening of the science and technology innovation construction in Baoshan District. Within two weeks, several biomedical industries including RNACure and H&B, have successively settled in Baoshan District, which greatly promotes the agglomeration of Baoshan biomedical industry.

微信图片_20220107091149.jpg

On the afternoon of January 6th, Baoshan District and Medicilon formally signed a strategic cooperation framework agreement, which added an important link to the Baoshan biomedical industry chain once more. Chen Jinzhang, Chairman of Medicilon, Chen Chunlin, Founder and CEO, Chen Jie, Secretary of Baoshan District Party Committee, Zhai Lei, Deputy Head of the District, and leaders of relevant departments of the Municipal Commission of Economy and Informatization attended the signing ceremony.

微信图片_20220107091152.jpg

Chen Jie hopes to keep steady and far-reaching achievements in the treasure land of Baoshan based on the early communication together with Medicilon. At present, the science and technology innovation construction in Baoshan District is developing rapidly from the early stage with the constantly improving quality and efficiency in industrial development, showing strong development potential. The scientific and technological innovations are developing continuously in an integrated manner, and a number of biomedical enterprises are gathering rapidly. Chen Jie said that by taking the signing of this agreement as an opportunity, he hoped that various departments can further coordinate and cooperate with each other, provide more practical services to enterprises, and speed up the project landing. Baoshan will provide better developing environment. And both the government and the enterprises should actively communicate with each other, remove the barriers, and solve difficulties in time so as to promote the high-quality development of enterprises.

微信图片_20220107091154.jpg

Chen Jinzhang, Chairman of Medicilon, said that the signing between Medicilon and Baoshan opened a new chapter for the leap-forward development of the enterprise, and Northern Shanghai Biomedical Industrial Park provided a new opportunity for the company's development. He also expressed his gratitude to the district party committee and government and relevant towns for their strong support, and said that in the future, the company would take this signing as a new start to continue to develop in Baoshan, speed up the project landing, and drive upstream and downstream enterprises in the industrial chain to settle in the park, making greater contributions to regional development.

微信图片_20220107091157.jpg

At the meeting, Chen Chunlin, founder and CEO of Medicilon, introduced the project.

The relevant personnel in charge of the Municipal Commission of Economy and Informatization congratulated Medicilon on choosing to settle in Baoshan for development and growth. Medicilon has taken root and developed in Shanghai, and its settlement in Baoshan will further conform to the development plan of the district and contribute to the biomedical layout of Shanghai.

微信图片_20220107091159.jpg

Medicilon is committed to providing all-round preclinical new drug research services for pharmaceutical companies, research institutions, and researchers around the world. It is one of the few well-known enterprises in China that can provide one-stop preclinical CRO services. With its highly specialized team, the company helps pharmaceutical companies reduce research and development costs, speed up the research and development process of new drugs, and continuously contribute to human health.

It took less than one month of communication between Baoshan and Medicilon in the early stage to sign the project, which well reflected Baoshan's determination and practical measures to accelerate the development of biomedical industry. Baoshan District undertakes the important mission of building the main position of science and technology innovation center and promoting the "northern transformation" entrusted by the Municipal Party Committee, and is entering the period of transformation and development. As one of the leading industries in Baoshan District, the biomedical industry has helped the gathering of a large number of high-quality enterprises within the industrial chain with Northern Shanghai Biomedical Industrial Park as the main body. Medicilon’s settlement in Northern Shanghai Biomedical Industrial Park is an important link for the development of the whole-chain biomedical industry in Baoshan District.

微信图片_20220107091201.jpg

On April 2020, Northern Shanghai Biomedical Industrial Park was recognized as Shanghai Municipal Biomedical Characteristic Industrial Park. Since then, a number of high-end biomedical enterprises such as Bao Pharmaceuticals, Chiatai Tianqing of Akesobio, and Huiyong Pharmaceutical have been attracted to settle down one after another. The construction of a number of specialized carriers such as Guosheng Baoshan Medicine Valley and Gold Concord MAX Science and Technology Park has been accelerated. The construction of professional platforms such as public laboratories, experimental animal centers, and Shanghai Institute of New Drug Innovation have been promoted vigorously, and comprehensive service institutions such as Shanghai Biomedical Product Registration Guidance Service Station and Baoshan District Market Supervision Bureau Service Direct Station have been listed in the park. A biomedical industry ecosystem has been formed initially.

当前页二维码
扫描二维码在手机上阅读
  • 宝山汇APP

  • 上海宝山微信

  • 上海宝山微博